Results of external beam radiotherapy alone for incompletely resected carcinoma of rectosigmoid or rectum: Peter MacCallum Cancer Institute experience 1981-1990
Mj. Guiney et al., Results of external beam radiotherapy alone for incompletely resected carcinoma of rectosigmoid or rectum: Peter MacCallum Cancer Institute experience 1981-1990, INT J RAD O, 43(3), 1999, pp. 531-536
Citations number
15
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Onconogenesis & Cancer Research
Journal title
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Purpose: To study the results of external beam radiotherapy treatment for i
ncompletely resected nonmetastatic rectosigmoid and rectal carcinoma.
Methods and Materials: A retrospective review was carried out of all patien
ts (57)presenting to Peter MacCallum Cancer Institute from 1981 to 1990 wit
h incompletely resected nonmetastatic rectosigmoid or rectal cancer who wer
e treated with external beam radiotherapy. Three radiotherapy schedules wer
e used: radical (50 to 60 Gy, 27 patients), high-dose palliative (45 Gy, 25
patients), and low-dose palliative (less than 45 Gy, 5 patients). Symptoma
tic response, overall survival, and the effect of prognostic factors on tre
atment outcome were evaluated. The median follow-up period for survivors wa
s 49 months.
Results: Symptomatic response rates were 83% and 79% for the radical and hi
gh-dose palliative groups respectively. The estimated median survival time
from presentation for all patients was 16.4 months (radical 26.1 months, hi
gh-dose palliative 15.7 months). Patients with microscopic residual disease
survived significantly longer than patients with macroscopic residual dise
ase (estimated median survival time 30.7 months vs. 14.3 months,p = 0.013).
Conclusions: No dose response effect was seen between the radical group and
high-dose palliative group. Microscopic residual disease at presentation w
as the only significant predictor of better survival. The conventionally fr
actionated course of 50 to 60 Gy was not significantly better in terms of p
alliation and overall survival than a shorter palliative course of 45 Gy. I
n future, preoperative chemoradiation should improve outcome by reducing th
e number of patients with incompletely resected cancer. (C) 1999 Elsevier S
cience Inc.